SIM
AGRX

Spark Investment Management’s Agile Therapeutics AGRX Stock Holding History

Spark Investment Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5
Closed -$64K – 870
2016
Q1 		$64K Buy
+5
New +$64.6K 0.01% 728
2015
Q2 		– Sell
-13
Closed -$231K – 755
2015
Q1 		$231K Buy
+13
New +$228K 0.03% 524

Other funds holding AGRX

PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Spark Investment Management's AGRX Position: Q2 2016 in Review

Spark Investment Management sold out of Agile Therapeutics (AGRX) in Q2 2016, closing a stake of 5 shares — an estimated $64K sold.

Spark Investment Management first reported a position in AGRX in Q1 2015 and held it in 2 quarters. The position peaked at $231K in Q1 2015. 50 funds tracked by Wall St. Rank hold AGRX as of Q2 2016.

  • Spark Investment Management reported no remaining Agile Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Spark Investment Management sold 5 Agile Therapeutics shares in Q2 2016, an estimated $64K.
  • Spark Investment Management first reported a position in Agile Therapeutics in Q1 2015 and held it in 2 quarters.
  • Spark Investment Management's Agile Therapeutics position peaked at $231K in Q1 2015.
  • 50 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2016.

Based on Spark Investment Management's 13F filing for Q2 2016, filed 12 Aug 2016.